Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for generalised myasthenia gravis (gMG).

A new COVID variant called "Nimbus" is spreading. Here's what you need to know about the incubation period, symptoms (including "razor blade throat") and when to take a test.